Download Dextromethorphan Overutilization - PAXpress

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Texas Prior Authorization Program
Clinical Edit Criteria
Drug/Drug Class
Dextromethorphan Overutilization
Clinical Edit Information Included in this Document

Drugs Requiring PA: the list of drugs requiring prior authorization for
this clinical edit

Drug Classification: classification of each drug requiring PA

Age and Dosing Limits: the maximum dose/day based on client’s age
and drug classification
Note: Click the hyperlink to navigate directly to that information.
Revision Notes
Updated GCNs and dosing guidelines
March 3, 2016
Copyright © 2016 Health Information Designs, LLC
1
Texas Prior Authorization Program Clinical Edits
Dextromethorphan Overutilization
Dextromethorphan Overutilization
Drug Classification
1. Obtain the client’s age. (Make a note of it for future reference.)
2. In the following table, locate the Classification associated with the incoming
request’s label name. (Make a note of it for future reference.)
3. Once you have located the classification, proceed to step 4 on the Age and
Dosing Limits page.
Drugs Requiring PA
Label Name
GCN
Classification
ALA-HIST DM LIQUID
AP-HIST DM LIQUID
ALLFEN DM TABLET
BROMFED DM COUGH SYRUP
BROMPHENIR-PSEUDOEPHEN-DM SYR
BROTAPP DM LIQUID
CHILD DELSYM COUGH+CHEST DM LQ
CHILDREN COLD & COUGH DM ELIXI
CHILDREN'S MUCINEX COUGH LIQ
CHILD MUCINEX CONGEST-COUGH LIQ
CHILD MUCINEX MULTI-SYMPTOM LIQ
COUGH DM ER 30MG/5ML SUSPENSION
COUGH & SORE THROAT LIQUID
DAYTIME COLD-FLU RLF SOFTGEL
DECONEX DMX TABLET
DELSYM 30 MG/5 ML SUSPENSION
DELSYM COUGH+CHEST CNGST DM LQ
DEXTROMETHORPHAN ER 30MG/5ML
DIMAPHEN DM ELIXIR
DURAFLU TABLET
ED-A-HIST DM LIQUID
ENDACOF-DM LIQUID
EXTRA ACTION COUGH SYRUP
HISTEX-DM SYRUP
IOPHEN DM-NR LIQUID
KIDKARE COUGH & COLD LIQUID
LOHIST PEB DM LIQUID
LOHIST-DM SYRUP
LORTUSS DM LIQUID
99356
99356
23807
96136
96136
12934
53497
26808
53497
28875
28875
17802
20556
25093
99656
17802
53497
17802
26808
18533
19347
26808
53495
36311
53491
96138
18314
15847
39565
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
March 3, 2016
Copyright © 2016 Health Information Designs, LLC
L
L
A
M
M
N
N
N
N
T
T
I
N
D
C
I
N
I
N
A
L
N
M
K
M
N
K
M
L
2
Texas Prior Authorization Program Clinical Edits
Dextromethorphan Overutilization
Drugs Requiring PA
Label Name
GCN
Classification
M-END DMX LIQUID
MAXIPHEN DM TABLET
MAPAP COLD FORMULA CAPLET
MUCINEX COUGH MINI-MELT PACK
MUCINEX DM ER 600-30 MG TABLET
MUCINEX DM ER 1,200-60 MG TAB
MUCINEX FAST-MAX CONGEST-COUGH
MUCINEX FAST-MAX DM MAX LIQUID
NIGHT TIME COLD-FLU RLF SFTGL
NOHIST-DM LIQUID
PEDIATRIC COUGH-COLD LIQUID
POLY-HIST DM LIQUID
POLY-VENT DM TABLET
PROMETHAZINE-DM SYRUP
Q-TUSSIN DM SYRUP
QC TUSSIN DM SYRUP
RESCON-DM LIQUID
ROBAFEN CF LIQUID
ROBAFEN-DM SYRUP
ROBAFEN DM COUGH LIQUID
RYNEX DM LIQUID
SILTUSSIN DM COUGH SYRUP
SILTUSSIN DM DAS LIQUID
SM TUSSIN DM SYRUP
TUSSIN DM CLEAR LIQUID
TUSSIN DM LIQUID
TUSSIN DM SYRUP
VANACOF DM LIQUID
VIRDEC DM DROPS
30801
99499
27135
99068
53550
99067
28875
53497
25094
19347
96138
34835
34799
13975
53495
53495
93335
53090
53495
53491
26808
53495
53491
53495
53495
53491
53495
34782
25730
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
Appendix
March 3, 2016
Copyright © 2016 Health Information Designs, LLC
M
A
D
E
Q
P
T
N
C
L
N
M
C
L
M
M
M
M
M
M
N
M
M
M
M
M
M
R
E
3
Texas Prior Authorization Program Clinical Edits
Dextromethorphan Overutilization
Dextromethorphan Overutilization
Age and Dosing Limits
4. Use the classification and client’s age to locate the dosing limit in the Maximum
Dose/Day column.
Age and Dosing Limits
Classification
Appendix A
Appendix C
Appendix D
Age
Maximum Dose/Day
6-11 years
12 years and older
6-11 years
12 years and older
6-11 years
12 years and older
3
6
4
8
6
12
units
units
units
units
units
units
Appendix E
6-11 years
12 units
Appendix I
4-5 years
6-11 years
12 years and older
5 ml
10 ml
20 ml
6-11 years
15 ml
12 years and older
6-11 years
12 years and older
30 ml
20 ml
40 ml
6-11 years
30 ml
12 years and older
60 ml
6-11 years
60 ml
6-11 years
12 years and older
6-11 years
12 years and older
6-11 years
12 years and older
6-11 years
12 years and older
1 unit
2 units
2 units
4 units
50 ml
100 ml
60 ml
120 ml
Appendix K
Appendix L
Appendix M
Appendix N
Appendix P
Appendix Q
Appendix R
Appendix T
March 3, 2016
Copyright © 2016 Health Information Designs, LLC
4
Texas Prior Authorization Program Clinical Edits
Dextromethorphan Overutilization
Publication History
The Publication History records the publication iterations and revisions to this
document. Notes for the most current revision are also provided in the
Revision Notes on the first page of this document.
Publication
Date
Notes
07/18/2012
Initial publication and posting to website
02/16/2016
Updated GCNS and dosing guidelines
March 3, 2016
Copyright © 2016 Health Information Designs, LLC
5
Related documents